Cells transformed to express on their surface a component which binds to an Fc receptor of
an effector cell are disclosed. Also disclosed are expression vectors used to transform the …

US20040131615A1 - Methods for treating pain by administering a nerve growth factor
antagonist and an opioid analgesic and compositions containing the same - Google Patents …

Methods and compositions for the development of effective cancer therapies using mitotic
inhibitors which have limited general toxicity to normal, non-cancerous cells and tissues are …

5,714,147 A 2/1998 Capon et al. 5,726,037 A 3/1998 Bodary et al. 5,726.290 A 3/1998
Bodary et al. 5,731,168 A 3/1998 Carter et al. 5,804,396 A* 9/1998 Plowman …

US20040146512A1 - Methods of treating Alzheimer's disease using antibodies directed
against amyloid beta peptide and compositions thereof - Google Patents …

RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O ([C@@ H] 1 [C@@] 2
(C [C@@ H](C (C)= C (C2 (C) C)[C@ H](C ([C@] 2 (C)[C@@ H](O) C [C@ H] 3OC [C@] 3 …

Disclosed are compositions and methods for enhancing a cytocidal immune response
directed against a preselected cell-type in a mammal. The methods and compositions rely …

(57) ABSTRACT A novel cytokine, designated Apo-2 ligand, which induces mammalian
cancer cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF …

US6764679B2 - Antibodies to DcR3 Polypeptide, a TNFR Homolog - Google Patents
US6764679B2 - Antibodies to DcR3 Polypeptide, a TNFR Homolog - Google Patents Antibodies …

the present invention relates to novel polypeptides, and the nucleic acids encoding them,
having properties related to stimulation of biochemical or physiological responses in a cell, a …